CRANIOFACIAL SKELETAL TISSUE ENGINEERING CONFERENCE

描述(由申请人提供)：本申请是一系列两年一度的会议中的第二次，其总体目标是促进在颅面科学和相关保健的重要领域取得进展。这一系列研讨会的具体目的是：(1)促进来自学术界、产业界和私人执业的临床医生、教育工作者和研究人员之间的协作互动；(2)促进新技术向临床实践的转化；(3)为学术和行业研究人员提供对临床相关领域的见解，以关注未来的发展；(4)教育学生并为年轻研究人员提供机会；以及(5)将研讨会系列建立为展示和讨论颅面科学前沿发展的论坛。每个专题讨论会都侧重于一个具体的主题领域。NIDCR支持的题为“21世纪的颅面成像”的首届研讨会非常成功，于2002年9月在加利福尼亚州太平洋格罗夫的Asilomar会议中心举行。下一次题为“颅面骨生物工程”的研讨会将于2004年8月27日至30日在同一地点举行。由于近年来生物工程组织的快速发展及其在颅面结构修复中的巨大应用潜力，这一课题既相关又及时。拟议的研讨会的目标是将生物工程的基础、翻译和临床方面的专家聚集在一起，提交论文和海报，参加讲座和小组讨论，并提出有助于推动该领域向前发展的概念。本次研讨会的具体目标是：(1)传播信息并讨论骨骼生物工程在以下领域的现状：(A)细胞和支架，(B)机械诱导和生物活性物质，(C)生物工程骨和软骨，以及(D)开发复杂的生物工程结构，如牙齿、关节和牙周组织。(2)确定、优先处理和讨论与生物工程组织临床应用相关的挑战，并制定能够使这些技术得到最佳利用的临床方案。(3)以出版论文集的形式传播研讨会报告。从学术界和临床实践中挑选了一批合格的演讲者，以确保举行一次高水平、具有智力挑战和富有成效的会议。会议将限于250名具有生物工程背景的与会者。

DESCRIPTION (provided by applicant): This application is for the second in a series of biennial conferences whose overall objective is to enhance advances in areas of importance to craniofacial sciences and related health care. The specific aims of this symposia series are to: (1) foster collaborative interactions among clinicians, educators and researchers from academics, industry and private practice; (2) enhance the transfer of novel technologies into clinical practice; (3) provide academic and industry researchers insights into clinically relevant areas in which to focus future developments; (4) educate students and provide opportunities for young investigators and (5) establish the symposia series as a forum for presentation and discussion of cutting-edge developments in craniofacial sciences. Each symposium focuses on a specific thematic area. The highly successful NIDCR supported inaugural symposium titled "Craniofacial Imaging in the 21st Century" was held in September 2002 at Asilomar Conference Center in Pacific Grove, California. The next symposium titled "Craniofacial Skeletal Bioengineering" will be held from August 27 to 30, 2004 at the same venue. Because of the recent rapid advances in bioengineered tissues and their tremendous potential for application to restoration of craniofacial structures, this topic is both relevant and timely. The objective for the proposed symposium is to bring together experts in basic, translational and clinical aspects of bioengineering to present papers and posters, to participate in lectures and small group discussions and propose concepts that will help drive this field forward. The specific goals of this symposium are to: (1) Disseminate information and discuss the current status of skeletal bioengineering in the areas of (a) cells and scaffolds, (b) mechanoinducitve and bioactive agents, (c) bioengineering bone and cartilage and (d) developing complex bioengineered structures such as teeth, joints and periodontium. (2) Identify, prioritize and discuss challenges related to clinical applications of bioengineered tissues and develop clinical protocols that will enable the optimum utilization of these technologies. (3) Disseminate symposium presentations by published proceedings. A broad spectrum of well qualified speakers from academics and clinical practice have been selected to ensure a high caliber, intellectually challenging and productive meeting. The meeting will be limited to 250 participants who have a background in bioengineering.